======= PRKAR2A ======= == Gene Information == * **Official Symbol**: PRKAR2A * **Official Name**: protein kinase cAMP-dependent type II regulatory subunit alpha * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5576|5576]] * **UniProt**: [[https://www.uniprot.org/uniprot/P13861|P13861]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PRKAR2A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRKAR2A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/176910|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. Type II regulatory chains mediate membrane association by binding to anchoring proteins, including the MAP2 kinase. |cNMP binding| |RIIa| |cAMP-dependent protein kinase regulator activity| |negative regulation of cAMP-dependent protein kinase activity| |cAMP-dependent protein kinase inhibitor activity| |cAMP-dependent protein kinase complex| |protein kinase A catalytic subunit binding| |nucleotide-activated protein kinase complex| |3,5-cyclic-GMP phosphodiesterase activity| |regulation of cAMP-dependent protein kinase activity| |activation of protein kinase A activity| |cAMP binding| |cGMP-mediated signaling| |cellular response to glucagon stimulus| |plasma membrane raft| |ciliary base| |renal water homeostasis| |response to glucagon| |multicellular organismal water homeostasis| |water homeostasis| |axoneme| |renal system process| |negative regulation of protein serine/threonine kinase activity| |cyclic-nucleotide-mediated signaling| |negative regulation of protein kinase activity| |protein domain specific binding| |negative regulation of kinase activity| |cellular response to peptide hormone stimulus| |negative regulation of transferase activity| |blood coagulation| |ubiquitin protein ligase binding| |coagulation| |hemostasis| |multicellular organismal homeostasis| |cellular response to peptide| |activation of protein kinase activity| |second-messenger-mediated signaling| |response to peptide hormone| |negative regulation of protein phosphorylation| |focal adhesion| |negative regulation of phosphorylation| |response to peptide| |wound healing| |centrosome| |regulation of body fluid levels| |regulation of protein serine/threonine kinase activity| |positive regulation of protein kinase activity| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |response to wounding| |positive regulation of kinase activity| |negative regulation of protein modification process| |protein-containing complex| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |positive regulation of transferase activity| |cellular response to nitrogen compound| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of kinase activity| |response to hormone| |regulation of transferase activity| |response to organonitrogen compound| |positive regulation of protein phosphorylation| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |response to nitrogen compound| |negative regulation of protein metabolic process| |chemical homeostasis| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |negative regulation of molecular function| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |response to endogenous stimulus| |response to oxygen-containing compound| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |homeostatic process| |intracellular signal transduction| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |system process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.81| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.73| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|1.92| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|2.1| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3281 * **Expression level (log2 read counts)**: 5.54 {{:chemogenomics:nalm6 dist.png?nolink |}}